Welcome to the Nutrition and Metabolic Epigenetics Group
The von Meyenn Group aims to gain insights into the complex relationship between nutrition, metabolism and the epigenome. We develop and use single-cell and next-generation sequencing techniques as well as human and murine in vivo and in vitro studies and combine these with genome-wide computational and bioinformatic analysis. We are interested in both fundamental biological discovery and potential therapies for human metabolic diseases. We hope that our work will contribute to the development of novel strategies to counter obesity and metabolic diseases.
On March 15th 2024, Laura successfully defended her PhD thesis titled “Shifting Landscapes: Exploring the Adipocyte Epigenome in Obesity, Weight Loss, and Changing Climates”. The whole lab congratules you Laura, well done!
Eva Galle and Laura Hinte were able to present their work at the 1. Swiss Nutrition Research Symposium at Agroscope, organized by the Swiss Research Network – Healthy Nutrition (SRN-HN). The main topics disscussed at this first symposium were how to make diets more sustainable and ways to increase metabolic health.
Guidelines to treat iron deficiency recommend daily provision of oral iron, but this may decrease fractional iron absorption and increase side effects. Our objective was to compare consecutive-day versus alternate-day iron supplementation.
Rebecca Richmond-Smith caught up with Ferdinand von Meyenn from Babraham Institute to talk about Epigenetics and his research into Vitamins A and C affecting Epigenetics.